Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain

Class:IdLiteratureReference:9856389
_displayNameExophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain
_timestamp2023-12-18 20:39:57
author[Person:6789454] Yu, Miao
[Person:9856388] Kasai, Kazuo
[Person:9856386] Nagashima, Kazuaki
[Person:6805366] Torii, Seiji
[Person:9856391] Yokota-Hashimoto, Hiromi
[Person:9856390] Okamoto, Koichi
[Person:9856385] Takeuchi, Toshiyuki
[Person:9856387] Gomi, Hiroshi
[Person:5676022] Izumi, Tetsuro
created[InstanceEdit:9856384] Rothfels, Karen, 2023-12-18
journalMol Biol Cell
pages688-96
pubMedIdentifier17182843
titleExophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain
volume18
year2007
(literatureReference)[Reaction:9856465] MLPH/MYRIP bind GGC-RAB27A and MYO5A [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain (9856389)